This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maestre, N. Articles by Jaffrézou, J.-P. Search for Related Content PubMed PubMed Citation Articles by Maestre, N. Articles by Jaffrézou, J.-P.

Cell Surface-directed Interaction of Anthracyclines Leads to Cytotoxicity and Nuclear Factor B Activation but not Apoptosis Signaling¹

Institut Nationale de la Santé et de la Recherche Médicale E9910, Institut Claudius Régaud, 31052 Toulouse, France [N. M., G. L., J-P. J.]; Haverford College, Haverford, Pennsylvania 19041 [T. R. T.]; and the Service d’Hématologie, Centre Hospitalier Universitaire Purpan, 31059 Toulouse, France [G. L.]

Anthracyclines are, above all, DNA intercalators, which induce genetic damage leading to cell death. However, increasing evidence firmly suggests that the underlying mechanism for anthracycline cytotoxicity is the induction of apoptosis through intracellular-mediated signaling pathways. Whether drug/DNA interaction is necessary for such apoptosis signaling is unknown. We investigated the cellular effects of the anthracyclines daunorubicin (DNR) and doxorubicin (DOX) using the myeloid leukemia cell line U937. By comparing free drug against agarose bead-immobilized drug iDNR and iDOX (which cannot accumulate within the cell), we observed that whereas both free and immobilized anthracyclines were cytotoxic, only the former induced apoptosis; the latter induced necrosis. Indeed, we did not observe ceramide generation, neutral sphingomyelinase activation, poly (ADP-ribose) polymerase cleavage, or other apoptotic events with iDNR or iDOX. However, both free and immobilized drug were similarly capable of triggering nuclear factor B activation. These observations demonstrate that whereas activation of certain cellular signaling pathways can be achieved solely through membrane interaction, apoptosis signaling requires anthracycline internalization. These results also show that the initiation of cell survival pathways (illustrated by nuclear factor B activation) is independent of intracellular drug/target interaction.

This article has been cited by other articles:

				Y.-Y. Liu, J. Y. Yu, D. Yin, G. A. Patwardhan, V. Gupta, Y. Hirabayashi, W. M. Holleran, A. E. Giuliano, S. M. Jazwinski, V. Gouaze-Andersson, et al. A role for ceramide in driving cancer cell resistance to doxorubicin FASEB J, July 1, 2008; 22(7): 2541 - 2551. [Abstract] [Full Text] [PDF]

				C. A. Corcoran, Q. He, S. Ponnusamy, B. Ogretmen, Y. Huang, and M. S. Sheikh Neutral Sphingomyelinase-3 Is a DNA Damage and Nongenotoxic Stress-Regulated Gene That Is Deregulated in Human Malignancies Mol. Cancer Res., May 1, 2008; 6(5): 795 - 807. [Abstract] [Full Text] [PDF]

				E. C. Attar, D. J. DeAngelo, J. G. Supko, F. D'Amato, D. Zahrieh, A. Sirulnik, M. Wadleigh, K. K. Ballen, S. McAfee, K. B. Miller, et al. Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia Clin. Cancer Res., March 1, 2008; 14(5): 1446 - 1454. [Abstract] [Full Text] [PDF]

				E. KEYHANI and J. KEYHANI Plasma Membrane Alteration Is an Early Signaling Event in Doxorubicin-Induced Apoptosis in the Yeast Candida utilis Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 369 - 376. [Abstract] [Full Text] [PDF]

				S. FOGLI, P. NIERI, and M. C. BRESCHI The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage FASEB J, April 1, 2004; 18(6): 664 - 675. [Abstract] [Full Text] [PDF]

				S. T. Sonis THE BIOLOGIC ROLE FOR NUCLEAR FACTOR-KAPPAB IN DISEASE AND ITS POTENTIAL INVOLVEMENT IN MUCOSAL INJURY ASSOCIATED WITH ANTI-NEOPLASTIC THERAPY Crit. Rev. Oral. Biol. Med., September 1, 2002; 13(5): 380 - 389. [Abstract] [Full Text] [PDF]

				E. Lorenzo, C. Ruiz-Ruiz, A. J. Quesada, G. Hernandez, A. Rodriguez, A. Lopez-Rivas, and J. M. Redondo Doxorubicin Induces Apoptosis and CD95 Gene Expression in Human Primary Endothelial Cells through a p53-dependent Mechanism J. Biol. Chem., March 22, 2002; 277(13): 10883 - 10892. [Abstract] [Full Text] [PDF]

				X. Bian, L. M. McAllister-Lucas, F. Shao, K. R. Schumacher, Z. Feng, A. G. Porter, V. P. Castle, and A. W. Opipari Jr. NF-kappa B Activation Mediates Doxorubicin-induced Cell Death in N-type Neuroblastoma Cells J. Biol. Chem., December 21, 2001; 276(52): 48921 - 48929. [Abstract] [Full Text] [PDF]